Author

Nishant Joshi

Eli Lilly (India)ORCID 0000-0001-7312-6112Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Aashima GuptaiD· 1 shared Evanka MadaniD· 1 shared Jhalak SinghaliD· 1 shared Monika SainiiD· 1 shared Ruby Bansal· 1 shared Sadat ShafiiD· 1 shared Shailja SinghiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

Aashima GuptaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

PathologyPLoS neglected tropical diseasesPeer-reviewedMar 20, 2026

Targeting Leishmania donovani Sphingosine Kinase 1 using PF-543 enhances immune response and limits parasite load

Evanka Madan, Ruby Bansal, Jhalak Singhal…·Shailja Singh

This paper evaluates PF-543, a SphK1 inhibitor, against Leishmania donovani, showing reduced parasite load and enhanced immune response both in vitro and in vivo.

DOI 10.1371/journal.pntd.0013102

mouseproteomics

𝕏 PostBluesky